Business description: Medtronic plc

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows:

- general and minimally invasive surgery (25%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;

- cardiac rhythm management (19%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;

- vascular diseases and cardiac surgery (18.1%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;

- cranial and spinal technologies (14.8%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;

- neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.7%);

- diabetes management (8.2%): internal and external glycemia monitoring systems and insulin pumps;

- neurological disorders (5.7%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ;

- other (0.5%).

Net sales are distributed geographically as follows: Ireland (0.3%), the United States (51.2%) and other (48.5%).

Number of employees: 95,000

Sales by Activity: Medtronic plc

Fiscal Period: April 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

Cardiovascular

1.08TCr 1.14TCr 1.16TCr 1.18TCr 1.25TCr

Neuroscience

819.5Cr 878.4Cr 895.9Cr 940.6Cr 984.6Cr

Medical Surgical

873.7Cr 914.1Cr 843.3Cr 841.7Cr 840.7Cr

Diabetes

241.3Cr 233.8Cr 226.2Cr 248.8Cr 275.5Cr

Other

- - - 22Cr 14Cr

Unallocated Other Adjustments

- - - - -9Cr

Geographical breakdown of sales: Medtronic plc

Fiscal Period: April 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

United States

1.55TCr 1.61TCr 1.64TCr 1.66TCr 1.72TCr

Rest of World

1.45TCr 1.54TCr 1.48TCr 1.57TCr 1.62TCr

Ireland

10Cr 10Cr 9.8Cr 11Cr 12Cr

Executive Committee: Medtronic plc

Manager TitleAgeSince
Chief Executive Officer 56 27/04/2020
Director of Finance/CFO 56 03/03/2025
Chief Tech/Sci/R&D Officer - 01/09/2020
Investor Relations Contact - 08/12/2025
Human Resources Officer - 01/01/2014

Composition of the Board of Directors: Medtronic plc

Director TitleAgeSince
Director/Board Member 66 26/01/2015
Director/Board Member 64 01/01/2013
Director/Board Member 70 01/01/2015
Director/Board Member 74 01/01/2014
Chairman 56 11/12/2020
Director/Board Member 72 01/01/2007
Director/Board Member 71 15/09/2020
Director/Board Member 57 27/06/2022
Director/Board Member 58 26/06/2023
Director/Board Member 64 18/06/2025

Shareholders: Medtronic plc

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
10.06 %
12,89,61,343 10.06 % 13 278 M $
BlackRock Advisors LLC
6.794 %
8,71,03,197 6.794 % 8 968 M $
4.81 %
6,16,60,158 4.81 % 6 349 M $
JPMorgan Investment Management, Inc.
4.185 %
5,36,52,761 4.185 % 5 524 M $
Capital Research & Management Co. (Global Investors)
2.697 %
3,45,73,163 2.697 % 3 560 M $

Holdings: Medtronic plc

NameEquities%Valuation
Anteris Technologies Global Corp.
37.99%
1,56,52,173 37.99% 93 M $
58,68,916 10.88% 20 M $

Company details: Medtronic plc

Medtronic Plc

Parkmore Business Park West

2, Galway

+353 1 438 1700

http://www.medtronic.com
address Medtronic plc(MDT)

Group companies: Medtronic plc

NameCategory and Sector
Information Technology Services
Investment Trusts/Mutual Funds
Medical Specialties
Medical Specialties
Medtronic Holding Hungary Kft.

Other Medical Equipment, Supplies & Distribution

Change 5d. change 1-year change 3-years change Capi.($)
-2.35%-6.79%-2.25%+11.11% 12TCr
-1.96%-6.38%-19.36%+6.01% 19TCr
-1.11%-4.15%+40.56%+127.98% 6.99TCr
+1.31%+0.87%+61.53%+102.20% 6.01TCr
-2.47%-5.76%-26.20%-29.60% 4.84TCr
-0.35%-8.78% - - 3.58TCr
-3.85%-6.13%-13.31%-39.13% 2.72TCr
-2.68%-7.58%+0.41%+25.27% 2.34TCr
-2.38%-9.28%-15.71%-46.83% 1.91TCr
+4.33%-2.32%-26.22%+13.49% 1.85TCr
Average -1.16%-4.64%-0.06%+18.94% 6.15TCr
Weighted average by Cap. -1.50%-4.33%+0.21%+25.94%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
93.01USD
Average target price
111.69USD
Spread / Average Target
+20.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MDT Stock
  4. Company Medtronic plc